FindTrial
Sign In

To assess the adverse effects after Homoeopathic treatment in patients of all age groups.

Adverse Drug Events from Homoeopathic Treatment: An Exploratory Pilot Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/089490
Enrollment
330
Registered
2025-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T887- Unspecified adverse effect of drugor medicament

Interventions

Intervention1: Nil: Nil

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. New patients visiting OPD for consultation during the study period. 2. Patients reporting with aggravation of the complaint/adverse event after homoeopathic treatment.

Exclusion criteria

Exclusion criteria: Patient/LAR who are unwilling to give informed consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the appearance of an adverse event after homoeopathic treatment.Timepoint: Every week to assess after dechallenge or rechallenge. Up to 4 weeks.—

Secondary

MeasureTime frame
NoneTimepoint: Not applicable—

Countries

India

Contacts

Public ContactDr Varanasi Roja

Central Research Institute (Homoeopathy), Lucknow

dramit911@gmail.com9140577532

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026